skip to content

Wellcome-MRC Cambridge Stem Cell Institute

 
Read more at: Degree of cell crowding in the early human embryo influences cell identity decision, new culture system finds
A cell aggregation of human pluripotent stem cells and amniotic ectoderm cells. Credit Shota Nakanoh

Degree of cell crowding in the early human embryo influences cell identity decision, new culture system finds

8 March 2024

Research published this week in Science Advances by Dr Shota Nakanoh in a collaboration between Dr Teresa Rayon’s lab at the Institute and Professor Ludovic Vallier’s lab at the Wellcome-MRC Cambridge Stem Cell Institute has determined that the degree of cell crowding in the early human embryo influences whether cells...


Read more at: New UKRI funding co-led by Walid Khaled will support research into better health, ageing, and wellbeing

New UKRI funding co-led by Walid Khaled will support research into better health, ageing, and wellbeing

12 February 2024

Professor Walid Khaled from CSCI and co-leader Dr Laura Greaves from Newcastle have received UKRI funding for research on age-related biological changes in model organisms as part of a national collaboration. UKRI funding of £3 million is awarded today (12 February) to support a new research cluster as part of the MRC...


Read more at: CSCI’s first Trainee Day kicks off SCI-TIF’s 2024 events programme

CSCI’s first Trainee Day kicks off SCI-TIF’s 2024 events programme

8 February 2024

This Tuesday (6 February), our Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF) and Institute researchers participated in our first SCI-TIF event of 2024, highlighting collaboration between industry and academia. The event started with an introduction from CSCI Director Bertie Gottgens, then...


Read more at: Professor Vassiliou to spearhead £4m project to develop clinical platform for blood cancer prevention with Blood Cancer UK and Leukemia & Lymphoma Society in the US

Professor Vassiliou to spearhead £4m project to develop clinical platform for blood cancer prevention with Blood Cancer UK and Leukemia & Lymphoma Society in the US

5 February 2024

On World Cancer Day yesterday (4 February), Blood Cancer UK and the American charity Leukemia & Lymphoma Society (LLS) announced the start of a transformative five-year, £4 million research project in Cambridge, spearheaded by CSCI’s Professor George Vassiliou. The project aims to establish a clinical platform to...


Read more at: Role of inherited genetic variants in rare blood cancer uncovered by CSCI researchers and collaborators
Blood cells

Role of inherited genetic variants in rare blood cancer uncovered by CSCI researchers and collaborators

17 January 2024

Large-scale genetic analysis has helped researchers uncover the interplay between cancer-driving genetic mutations and inherited genetic variants in a rare type of blood cancer. Researchers from the Wellcome-MRC Cambridge Stem Cell Institute, Wellcome Sanger Institute, the University of Cambridge, and collaborators...


Read more at: Göttgens Group publishes research on a new model

Göttgens Group publishes research on a new model

8 January 2024

A new collaborative paper from the Göttgens , Kranc and O’Carroll groups reports the first model of homeostatic in vivo tissue dynamics that is anchored in single cell genomics data in the Cell Stem Cell publication out last week (5 January). In time series measurements extending over 9 months, the Kranc Group (Institute...


Read more at: PI Kostas Tzelepis presents at the 65th Annual ASH Conference on STORM Therapeutics’ First-in-Class tRNA methyltransferase inhibitor
I Kostas Tzelepis presents at the 65th Annual ASH Conference

PI Kostas Tzelepis presents at the 65th Annual ASH Conference on STORM Therapeutics’ First-in-Class tRNA methyltransferase inhibitor

12 December 2023

On Friday 8 December, CSCI PI Kostantinos Tzelepis presented his research at the Annual American Society of Hematology (ASH) Meeting in San Diego, USA. This presentation focused on the pre-clinical development and characterisation of the first-in-class METTL1 RNA Methyltransferase inhibitor, a totally novel anticancer...


Read more at: CSCI celebrates second annual Christmas Market

CSCI celebrates second annual Christmas Market

11 December 2023

On Friday 1 December, CSCI celebrated our second annual Christmas Market at the Jeffrey Cheah Biomedical Centre . Partnering with our neighbours at Cancer Research UK Cambridge Institute and Cambridge Biomedical Campus , and with volunteers from The Milner Therapeutics Institute and Cambridge Institute of Therapeutic...


Read more at: Dr Alecia-Jane Twigger wins major Fellowship award to establish a Cambridge lactation lab
Dr Alecia-Jane Twigger looking through microscope

Dr Alecia-Jane Twigger wins major Fellowship award to establish a Cambridge lactation lab

4 December 2023

It was announced today that Dr Alecia-Jane Twigger has been awarded a UK Research and Innovation (UKRI) Future Leaders Fellowship. These Fellowships are awarded by UKRI to support universities and businesses in developing their most talented early career researchers and innovators. Dr Twigger, a Research Associate in...


Read more at: Dr Konstantinos Tzelepis named as an Emerging Leader in Leukaemia

Dr Konstantinos Tzelepis named as an Emerging Leader in Leukaemia

25 October 2023

Last week, the journal Leukemia announced CSCI PI Dr Konstantinos Tzelepis as one of three Emerging Leaders in Leukemia. The Nature Publishing Group journal’s Emerging Leaders collection selects rising talent in the field of haematology, providing a spotlight so they can share their work with others. Kostas and his group...